Assoc. Director, Medicinal Chemistry
Hyderabad, Telangana, India
Assoc. Director, Medicinal Chemistry
Let’s build the future of medicine—together.
Associate Director, Medicinal Chemistry
Hyderabad, India | Full-Time
YOUR ROLE
As Associate Director, Medicinal Chemistry at Enveda, you will shape scientific strategy, lead high-performing medicinal chemistry teams, and advance innovative small molecules from lead generation through candidate nomination. Reporting to the VP of Discovery Chemistry, you will be a scientific leader who drives SAR strategy, mentors future scientific leaders, and represents programmes confidently to global leadership and external collaborators — all while building one of the world's leading medicinal chemistry teams.
WHAT YOU'LL DO
-
Lead medicinal chemistry strategy from hit identification through candidate nomination; drive molecule design using SAR, SPR, DMPK, and AI insights
-
Develop study flow schemes integrating in vitro, in vivo, ADME/PK, and tox data to inform programme decisions
-
Mentor scientists to become independent medicinal chemists and future scientific leaders; build a culture of scientific excellence and curiosity
-
Represent programmes confidently to global leadership and external collaborators; collaborate with Biology, DMPK, Computational Chemistry, and IP teams
-
Leverage AI-enabled molecular design and data-driven decision-making to accelerate the design-make-test-analyse cycle
WHAT WE'RE LOOKING FOR
-
PhD in Medicinal Chemistry or Synthetic Organic Chemistry with 15-18 years of integrated drug discovery experience; international postdoctoral or global pharma experience preferred
-
Demonstrated track record of progressing one or more programmes to candidate nomination or clinical development
-
Ability to mentor and lead multiple teams and projects in parallel
-
Strong understanding of intellectual property — composition of matter, method of use, and chemical processes
-
Outstanding scientific communication and presentation skills
ABOUT ENVEDA
We're a clinical-stage, AI-enabled biotech discovering medicines four times faster than the industry standard.
We recently raised $150M in a Series D, reached unicorn status, and advanced our first drug into Phase 2 trials. Forbes named us one of America's Best Startup Employers. Newsweek recognized us as a Top 100 Most Loved Workplace.
We're building something rare and we're just getting started!